Xymogen

MaX DeFlam

D
N+ Score64
Longevity & NAD+Serving: 1 Capsule(s)Type: Other Combinations

MaX DeFlam by Xymogen is an 'Other Combinations' supplement categorized under Longevity & NAD+, featuring a blend of botanical extracts. This product includes Boswellia serrata Extract (50.000mg), Milk Thistle (50.000mg), Turmeric Extract (30.000mg), and Ginger Extract (20.000mg) per 1 capsule serving. Notably, none of the listed ingredients are present at clinically studied doses in this formulation. With a total of 10 ingredients, this product received an N+ Score of 64, earning a 'D' grade, placing it in the average tier. It may appeal to individuals interested in a blend of traditional herbal ingredients, though specific ingredient dosages may warrant further consideration.

About This Product

MaX DeFlam by Xymogen is a longevity & nad+ supplement containing 10 active ingredients. It has earned an N+ Score of 64/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (10 ingredients)

IngredientAmountDose Adequacy
Alpha Lipoic Acid1.000 mgN/A
Quercetin5.000 mgN/A
Milk Thistle50.000 mgN/A
Ginger extract20.000 mgN/A
Turmeric extract30.000 mgN/A
Lemon Bioflavonoids20.000 mgN/A
Milk Thistle extract5.000 mgN/A
Boswellia serrata extract50.000 mgN/A
S-Acetyl Glutathione2.000 mgN/A
Siberian and Dahurian Larch Tree extract1.200 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.